Fractals: Life Science Conversations
Measuring What Matters: Biomarkers, Imaging, and Statistical Rigor with Guest David Raunig
· 25 min · Épisode 20
Notes d’épisode
With more than two decades of experience at the intersection of biostatistics and biomedical imaging, Bracken Senior Partner Dr. David Raunig has been a driving force in biomarker development, validation, and regulatory strategy. From leading FDA biomarker qualification review teams to co-inventing imaging advancements and setting industry-wide standards through QIBA, David has played a pivotal role in defining how we measure—and trust—biological data in clinical trials.
In this episode of Fractals: Life Science Conversations, David and host Colin Miller explore:
• What truly defines a…
Site web: fractals-a-bracken-podcast.simplecast.com
